<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Eur J Hum Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Eur. J. Hum. Genet</journal-id>
<journal-title-group>
<journal-title>European Journal of Human Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1018-4813</issn>
<issn pub-type="epub">1476-5438</issn>
<publisher>
<publisher-name>Nature Publishing Group</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27406250</article-id>
<article-id pub-id-type="pmc">5117934</article-id>
<article-id pub-id-type="pii">ejhg201685</article-id>
<article-id pub-id-type="doi">10.1038/ejhg.2016.85</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genotype and brain pathology phenotype in children with tuberous sclerosis complex</article-title>
<alt-title alt-title-type="running">Genotype/phenotype in tuberous sclerosis complex</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Overwater</surname>
<given-names>Iris E</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Swenker</surname>
<given-names>Rob</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>van der Ende</surname>
<given-names>Emma L</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hanemaayer</surname>
<given-names>Kimberley BM</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hoogeveen-Westerveld</surname>
<given-names>Marianne</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>van Eeghen</surname>
<given-names>Agnies M</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lequin</surname>
<given-names>Maarten H</given-names>
</name>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>van den Ouweland</surname>
<given-names>Ans MW</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moll</surname>
<given-names>Henriëtte A</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nellist</surname>
<given-names>Mark</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Wit</surname>
<given-names>Marie-Claire Y</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="corresp" rid="caf1">*</xref>
</contrib>
<aff id="aff1"><label>1</label><institution>Department of Neurology, Erasmus Medical Center</institution>, Rotterdam, <country>The Netherlands</country></aff>
<aff id="aff2"><label>2</label><institution>ENCORE-TSC Expertise Center, Erasmus Medical Center</institution>, Rotterdam, <country>The Netherlands</country></aff>
<aff id="aff3"><label>3</label><institution>Department of Clinical Genetics, Erasmus Medical Center</institution>, Rotterdam, <country>The Netherlands</country></aff>
<aff id="aff4"><label>4</label><institution>Department of Pediatrics, Erasmus Medical Center</institution>, Rotterdam, <country>The Netherlands</country></aff>
<aff id="aff5"><label>5</label><institution>Department of Radiology, University Medical Centre Utrecht</institution>, Utrecht, <country>The Netherlands</country></aff>
</contrib-group>
<author-notes>
<corresp id="caf1"><label>*</label><institution>Department of Neurology, ENCORE-TSC Expertise Center, Erasmus Medical Centre-Sophia Children's Hospital</institution>, Room Sk-2212, PO Box 2060, 3000 CB, Rotterdam, <country>The Netherlands</country>. Tel: +31 0 10 703 6341; Fax: +31 0 10 703 6345; E-mail: <email>m.c.y.dewit@erasmusmc.nl</email></corresp>
<fn fn-type="COI-statement">
<p>R Swenker reports financial assistance from Novartis. MCY de Wit reports grants from Dutch Epilepsy Foundation, and grants and non-financial support from Novartis outside the submitted work; and the Erasmus MC received honoraria from Novartis for educational lectures presented by the author. The remaining authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>13</day>
<month>07</month>
<year>2016</year>
</pub-date>
<volume>24</volume>
<issue>12</issue>
<fpage>1688</fpage>
<lpage>1695</lpage>
<history>
<date date-type="received">
<day>13</day>
<month>01</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>04</day>
<month>06</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>06</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016 Macmillan Publishers Limited</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Macmillan Publishers Limited</copyright-holder>
</permissions>
<abstract>
<p>Structural brain malformations associated with Tuberous Sclerosis Complex (TSC) are related to the severity of the clinical symptoms and can be visualized by magnetic resonance imaging (MRI). Tuberous Sclerosis Complex is caused by inactivating <italic>TSC1</italic> or <italic>TSC2</italic> mutations. We investigated associations between TSC brain pathology and different inactivating <italic>TSC1</italic> and <italic>TSC2</italic> variants, and examined the potential prognostic value of subdivision of <italic>TSC2</italic> variants based on their predicted effects on <italic>TSC2</italic> expression. We performed genotype-phenotype associations of TSC-related brain pathology on a cohort of 64 children aged 1.4–17.9 years. Brain abnormalities were assessed using MRI. Individuals were grouped into those with an inactivating <italic>TSC1</italic> variant and those with an inactivating <italic>TSC2</italic> variant. The <italic>TSC2</italic> group was subdivided into changes predicted to result in TSC2 protein expression (<italic>TSC2</italic>p) and changes predicted to prevent expression (<italic>TSC2</italic>x). The <italic>TSC2</italic> group was associated with more and larger tubers, more radial migration lines, and more subependymal nodules than the <italic>TSC1</italic> group. Subependymal nodules were also more likely to be calcified. Subdivision of the <italic>TSC2</italic> group did not reveal additional, substantial differences, except for a larger number of tubers in the temporal lobe and a larger fraction of cystic tubers in the <italic>TSC2</italic>x subgroup. The severity of TSC-related brain pathology was related to the presence of an inactivating <italic>TSC2</italic> variant. Although larger studies might find specific <italic>TSC2</italic> variants that have prognostic value, in our cohort, subdivision of the <italic>TSC2</italic> group did not lead to better prediction.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>